Please provide your email address to receive an email when new articles are posted on . The test met its primary endpoint of concordance with intended use, which was 99%. Patients with a positive ...

The Centers for Medicare & Medicaid Services (CMS) announced Thursday that its Innovation Center is launching a pair of 5-year demonstration projects aimed at evaluating different approaches to shared ...

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

Many seriously ill patients receive much of their care at home from one or more family members. However, shared decision making (SDM)—the collaborative process whereby clinicians and patients work ...